Co-Diagnostics, Inc. has canceled its 2026 Annual Meeting of Stockholders after failing to achieve the required quorum on four separate occasions. The company was unable to transact business and has decided not to adjourn the meeting further, instead planning to hold a special meeting at a future date.
Key Details
- Failed Quorum: The Annual Meeting, originally set for September 3, 2026, was subsequently adjourned to September 24, September 30, and finally October 14, 2026, without reaching a quorum at any attempt.
- Meeting Canceled: After the final attempt on October 14, 2026, the company determined not to adjourn the Annual Meeting again.
- Future Plans: The company intends to seek stockholder approval for the proposals at a special meeting of stockholders to be held on a future, unannounced date.